- Home
- NBY vs FFA Comparison
NBY vs FFA Comparison
Compare NBY & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- FFA
- Stock Information
- Founded
- NBY 2000
- FFA 2004
- Country
- NBY United States
- FFA United States
- Employees
- NBY N/A
- FFA N/A
- Industry
- NBY
- FFA Investment Managers
- Sector
- NBY
- FFA Finance
- Exchange
- NBY Nasdaq
- FFA Nasdaq
- Market Cap
- NBY 3.5M
- FFA N/A
- IPO Year
- NBY 2007
- FFA N/A
- Fundamental
- Price
- NBY $0.71
- FFA $20.05
- Analyst Decision
- NBY
- FFA
- Analyst Count
- NBY 0
- FFA 0
- Target Price
- NBY N/A
- FFA N/A
- AVG Volume (30 Days)
- NBY 7.7M
- FFA 26.1K
- Earning Date
- NBY 11-07-2024
- FFA 01-01-0001
- Dividend Yield
- NBY N/A
- FFA 6.72%
- EPS Growth
- NBY N/A
- FFA N/A
- EPS
- NBY N/A
- FFA N/A
- Revenue
- NBY $13,884,000.00
- FFA N/A
- Revenue This Year
- NBY N/A
- FFA N/A
- Revenue Next Year
- NBY $26.04
- FFA N/A
- P/E Ratio
- NBY N/A
- FFA N/A
- Revenue Growth
- NBY 4.06
- FFA N/A
- 52 Week Low
- NBY $0.07
- FFA $15.84
- 52 Week High
- NBY $6.30
- FFA $19.30
- Technical
- Relative Strength Index (RSI)
- NBY 55.65
- FFA 50.90
- Support Level
- NBY $0.64
- FFA $19.85
- Resistance Level
- NBY $0.71
- FFA $20.63
- Average True Range (ATR)
- NBY 0.08
- FFA 0.23
- MACD
- NBY 0.02
- FFA -0.04
- Stochastic Oscillator
- NBY 43.40
- FFA 25.64
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.